Mathematical Models and Computer Simulation of Chemical Carcinogenesis Process and its Inhibition by Anticarcinogenic

Paraskeui Koutsi1, Spyros Ch Karkabounas2, George Manis3

  • 1Lab of Bioinformatics, Department of Computer Science & Engineering, University of Ioannina, Ioannina, Greece. paraskeuikout@gmail.com.

Insights

This study uses mathematical models to understand how 3,4-benzopyrene causes cancer and affects malignant tumor growth in experimental animals. The research aims to optimize models for chemical carcinogenesis and tumor inhibition.

Area of Science:

  • Oncology
  • Mathematical Biology
  • Toxicology

Background:

  • Cancer research has advanced significantly due to technological progress and targeted therapies.
  • Chemical carcinogenesis is a complex process involving exposure to carcinogens like 3,4-benzopyrene.
  • Understanding tumor development is crucial for effective cancer treatment strategies.

Purpose of the Study:

  • To investigate mathematical models for optimal description of malignant tumor development.
  • To study the phenomenon of chemical carcinogenesis induced by 3,4-benzopyrene.
  • To analyze tumor inhibition and growth dynamics.

Main Methods:

  • Utilizing mathematical modeling to simulate tumor development.
  • Employing experimental animal models for chemical carcinogenesis studies.
  • Analyzing data related to 3,4-benzopyrene exposure and subsequent tumor progression.

Main Results:

  • Established optimal mathematical models for describing chemically induced tumors.
  • Characterized the process of chemical carcinogenesis in the experimental setting.
  • Quantified aspects of tumor inhibition and growth patterns.

Conclusions:

  • Mathematical models provide a powerful tool for understanding cancer development.
  • The study offers insights into the mechanisms of 3,4-benzopyrene-induced carcinogenesis.
  • Findings contribute to the broader field of cancer research and therapeutic development.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
578
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
291
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
190